Verda Bio

Panelists from previous talks returned to field questions on identifying and regulating impairing cannabinoids, goals much more difficult to reach for cannabis than for alcohol.

WSLCB staff planned to renew public dialogue about impairing versus non-impairing cannabinoids, providing an opportunity to question how helpful that dichotomy actually is.

A last-minute hearing on a repackaged bill to regulate synthesized cannabinoids revealed shared public health concerns but testimony otherwise remained just as sharply divided.

Testimony on legislation to revise regulation of cannabinoids emphasized policy pitfalls versus prospective benefits, and hinted at fiscal fallout from litigious hemp industry interests.

Two visions for the future of cannabinoid regulation were presented to senators, with testimony split between a measure developed by WACA members and WSLCB request legislation.

Some licensees, WSLCB staff, and prevention advocates encouraged lawmakers to pass request legislation on cannabinoid regulation, while other licensees preferred a competing bill.

This week would include interesting events covering a broad spectrum of cannabis-related topics including social equity, behavioral health, delta-8-THC, and substance use prevention.